Cargando…

From OPC to Oligodendrocyte: An Epigenetic Journey

Oligodendrocytes provide metabolic and functional support to neuronal cells, rendering them key players in the functioning of the central nervous system. Oligodendrocytes need to be newly formed from a pool of oligodendrocyte precursor cells (OPCs). The differentiation of OPCs into mature and myelin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiane, Assia, Schepers, Melissa, Rombaut, Ben, Hupperts, Raymond, Prickaerts, Jos, Hellings, Niels, van den Hove, Daniel, Vanmierlo, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830107/
https://www.ncbi.nlm.nih.gov/pubmed/31614602
http://dx.doi.org/10.3390/cells8101236
_version_ 1783465711025258496
author Tiane, Assia
Schepers, Melissa
Rombaut, Ben
Hupperts, Raymond
Prickaerts, Jos
Hellings, Niels
van den Hove, Daniel
Vanmierlo, Tim
author_facet Tiane, Assia
Schepers, Melissa
Rombaut, Ben
Hupperts, Raymond
Prickaerts, Jos
Hellings, Niels
van den Hove, Daniel
Vanmierlo, Tim
author_sort Tiane, Assia
collection PubMed
description Oligodendrocytes provide metabolic and functional support to neuronal cells, rendering them key players in the functioning of the central nervous system. Oligodendrocytes need to be newly formed from a pool of oligodendrocyte precursor cells (OPCs). The differentiation of OPCs into mature and myelinating cells is a multistep process, tightly controlled by spatiotemporal activation and repression of specific growth and transcription factors. While oligodendrocyte turnover is rather slow under physiological conditions, a disruption in this balanced differentiation process, for example in case of a differentiation block, could have devastating consequences during ageing and in pathological conditions, such as multiple sclerosis. Over the recent years, increasing evidence has shown that epigenetic mechanisms, such as DNA methylation, histone modifications, and microRNAs, are major contributors to OPC differentiation. In this review, we discuss how these epigenetic mechanisms orchestrate and influence oligodendrocyte maturation. These insights are a crucial starting point for studies that aim to identify the contribution of epigenetics in demyelinating diseases and may thus provide new therapeutic targets to induce myelin repair in the long run.
format Online
Article
Text
id pubmed-6830107
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68301072019-11-20 From OPC to Oligodendrocyte: An Epigenetic Journey Tiane, Assia Schepers, Melissa Rombaut, Ben Hupperts, Raymond Prickaerts, Jos Hellings, Niels van den Hove, Daniel Vanmierlo, Tim Cells Review Oligodendrocytes provide metabolic and functional support to neuronal cells, rendering them key players in the functioning of the central nervous system. Oligodendrocytes need to be newly formed from a pool of oligodendrocyte precursor cells (OPCs). The differentiation of OPCs into mature and myelinating cells is a multistep process, tightly controlled by spatiotemporal activation and repression of specific growth and transcription factors. While oligodendrocyte turnover is rather slow under physiological conditions, a disruption in this balanced differentiation process, for example in case of a differentiation block, could have devastating consequences during ageing and in pathological conditions, such as multiple sclerosis. Over the recent years, increasing evidence has shown that epigenetic mechanisms, such as DNA methylation, histone modifications, and microRNAs, are major contributors to OPC differentiation. In this review, we discuss how these epigenetic mechanisms orchestrate and influence oligodendrocyte maturation. These insights are a crucial starting point for studies that aim to identify the contribution of epigenetics in demyelinating diseases and may thus provide new therapeutic targets to induce myelin repair in the long run. MDPI 2019-10-11 /pmc/articles/PMC6830107/ /pubmed/31614602 http://dx.doi.org/10.3390/cells8101236 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tiane, Assia
Schepers, Melissa
Rombaut, Ben
Hupperts, Raymond
Prickaerts, Jos
Hellings, Niels
van den Hove, Daniel
Vanmierlo, Tim
From OPC to Oligodendrocyte: An Epigenetic Journey
title From OPC to Oligodendrocyte: An Epigenetic Journey
title_full From OPC to Oligodendrocyte: An Epigenetic Journey
title_fullStr From OPC to Oligodendrocyte: An Epigenetic Journey
title_full_unstemmed From OPC to Oligodendrocyte: An Epigenetic Journey
title_short From OPC to Oligodendrocyte: An Epigenetic Journey
title_sort from opc to oligodendrocyte: an epigenetic journey
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830107/
https://www.ncbi.nlm.nih.gov/pubmed/31614602
http://dx.doi.org/10.3390/cells8101236
work_keys_str_mv AT tianeassia fromopctooligodendrocyteanepigeneticjourney
AT schepersmelissa fromopctooligodendrocyteanepigeneticjourney
AT rombautben fromopctooligodendrocyteanepigeneticjourney
AT huppertsraymond fromopctooligodendrocyteanepigeneticjourney
AT prickaertsjos fromopctooligodendrocyteanepigeneticjourney
AT hellingsniels fromopctooligodendrocyteanepigeneticjourney
AT vandenhovedaniel fromopctooligodendrocyteanepigeneticjourney
AT vanmierlotim fromopctooligodendrocyteanepigeneticjourney